| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.43B | 56.40B | 52.04B | 45.79B | 47.07B | 41.18B |
| Gross Profit | 9.73B | 9.80B | 9.72B | 7.09B | 8.31B | 7.27B |
| EBITDA | 4.25B | 4.67B | 5.17B | 2.79B | 4.33B | 3.83B |
| Net Income | 781.00M | 1.10B | 1.96B | 348.00M | 1.68B | 1.44B |
Balance Sheet | ||||||
| Total Assets | 56.39B | 60.50B | 61.84B | 53.58B | 54.92B | 52.97B |
| Cash, Cash Equivalents and Short-Term Investments | 10.73B | 11.13B | 14.77B | 10.71B | 10.58B | 11.66B |
| Total Debt | 569.00M | 595.00M | 358.00M | 456.00M | 544.00M | 854.00M |
| Total Liabilities | 19.57B | 23.09B | 24.27B | 19.05B | 20.24B | 19.53B |
| Stockholders Equity | 35.69B | 36.23B | 36.33B | 33.49B | 33.79B | 32.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.44B | 4.52B | 248.00M | 476.00M | 1.12B |
| Operating Cash Flow | 0.00 | 1.33B | 7.11B | 2.96B | 2.97B | 2.75B |
| Investing Cash Flow | 0.00 | -4.49B | -1.92B | -1.94B | -2.75B | -2.37B |
| Financing Cash Flow | 0.00 | -1.29B | -587.00M | -703.00M | -1.42B | -781.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥40.23B | 5.81 | ― | 3.53% | -3.45% | 30.52% | |
73 Outperform | ¥181.15B | 14.03 | 4.41% | 3.80% | -1.50% | -32.46% | |
67 Neutral | ¥103.03B | 10.01 | ― | 3.88% | 2.61% | 30.29% | |
65 Neutral | ¥78.42B | 17.82 | ― | 0.67% | 10.18% | -14.36% | |
64 Neutral | ¥23.89B | 17.30 | ― | 4.09% | 3.31% | -70.30% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
50 Neutral | ¥20.98B | 15.68 | ― | 1.39% | -0.12% | ― |